Research output per year
Research output per year
Search results
-
2015
Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischaemic stroke in the third International Stroke Trial (IST-3): secondary analysis of a randomised controlled trial
The IST-3 Collaborative Group , 1 May 2015, In: Lancet Neurology. 14, 5, p. 485-496 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Observer reliability of CT angiography in the assessment of acute ischaemic stroke: data from the Third International Stroke Trial
The IST-3 Collaborative Group , Jan 2015, In: Neuroradiology. 57, 1, p. 1-9 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2014
Effect of Alteplase Within 6 Hours of Acute Ischemic Stroke on All-Cause Mortality (Third International Stroke Trial)
IST-3 Collaborative Grp, Whiteley, W. N., Thompson, D., Murray, G., Cohen, G., Lindley, R. I., Wardlaw, J. & Sandercock, P., Dec 2014, In: Stroke. 45, 12, p. 3612-3617 6 p.Research output: Contribution to journal › Article › peer-review
-
Targeting Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Based on Risk of Intracranial Hemorrhage or Poor Functional Outcome An Analysis of the Third International Stroke Trial
IST-3 Collaborat Grp, Whiteley, W. N., Thompson, D., Murray, G., Cohen, G., Lindley, R. I., Wardlaw, J. & Sandercock, P., Apr 2014, In: Stroke. 45, 4, p. 1000-1006 7 p.Research output: Contribution to journal › Article › peer-review
-
2013
Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial
IST-3 Collaborative Group, Wardlaw, J., Dennis, M., Cohen, G., Murray, G., Innes, K., Whiteley, W., Lindley, R., Venables, G., Czlonkowska, A., Kobayashi, A., Ricci, S., Murray, V., Berge, E., Bruins Slot, K., Hankey, G., Correia, M., Peeters, A., Matz, K., Lyrer, P., & 3 others, 1 Aug 2013, In: Lancet Neurology. 12, 8, p. 768-776Research output: Contribution to journal › Article › peer-review
Open AccessFile -
2012
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
Sandercock, P., Wardlaw, J. M., Lindley, R. I., Dennis, M., Cohen, G., Murray, G., Innes, K., Venables, G., Czlonkowska, A., Kobayashi, A., Ricci, S., Murray, V., Berge, E., Slot, K. B., Hankey, G. J., Correia, M., Peeters, A., Matz, K., Lyrer, P., Gubitz, G., & 5 others, Jun 2012, In: The Lancet. 379, 9834, p. 2352-2363 12 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L. & Cohen, G., 2012, In: The Lancet. 379, 9834, p. 2364-72 9 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile